PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Clinical trials for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for halting deadly lung scarring
Disease control OngoingThis study is testing whether a new drug called ENV-101 can help slow down lung scarring and improve breathing in adults with idiopathic pulmonary fibrosis (IPF), a serious lung disease. About 213 participants will receive either one of three doses of ENV-101 or a placebo for six…
Matched conditions: PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New scan seeks to spot lung damage earlier
Knowledge-focused OngoingThis study is testing whether a new type of MRI scan, using a special inhaled gas called hyperpolarized xenon, can better detect and monitor lung scarring (fibrosis) and related heart effects in people with progressive fibrosing lung disease. It aims to see if this scan is more s…
Matched conditions: PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC